CDTX vs CNC · rev $1.3M vs P/E 8.4, rev $163.07B
Cidara Therapeutics Inc (CDTX) versus Centene Corp (CNC) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Centene Corp (CNC) is a healthcare plans company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported CNC revenue for 2024-12-31 was $163.07B. Net income was $3.29B. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
CDTX currently screens at market cap $6.96B. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Not investment advice. Open the CDTX and CNC stock pages for the full models.
Not investment advice.